Biogen Inc. buy hoffi69
Start price
01.11.12
/
50%
€106.94
Target price
01.02.13
€120.00
Performance (%)
6.61%
End price
01.02.13
€114.00
Summary
This prediction ended on 01.02.13 with a price of €114.00. The BUY prediction by hoffi69 finished with a performance of 6.61%. hoffi69 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 10.992% | 10.992% | 75.048% | -26.476% |
| iShares Core DAX® | -1.358% | -2.329% | 3.438% | 53.509% |
| iShares Nasdaq 100 | -3.700% | -1.242% | 33.079% | 90.966% |
| iShares Nikkei 225® | -2.512% | 6.914% | 60.778% | 81.100% |
| iShares S&P 500 | -1.662% | -0.643% | 23.467% | 67.066% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
(Reuptake) Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt es sich nach dem Rücksetzer bei Biogen einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)


